Cargando…

Harnessing Natural Mosaics: Antibody-Instructed, Multi-Envelope HIV-1 Vaccine Design

The year 2021 marks the 40th anniversary since physicians recognized symptoms of the acquired immunodeficiency syndrome (AIDS), a disease that has since caused more than 30 million deaths worldwide. Despite the passing of four decades, there remains no licensed vaccine for the human immunodeficiency...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sealy, Robert E., Dayton, Barry, Finkelstein, David, Hurwitz, Julia L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151930/ https://www.ncbi.nlm.nih.gov/pubmed/34064894 http://dx.doi.org/10.3390/v13050884

Ejemplares similares

How Basic Immunological Principles May Instruct the Design of a Successful HIV-Type 1 Vaccine
por: Slobod, Karen S., et al.
Publicado: (2020)

Harnessing Activin A Adjuvanticity to Promote Antibody Responses to BG505 HIV Envelope Trimers
por: Carnathan, Diane G., et al.
Publicado: (2020)

Effect of HIV Envelope Vaccination on the Subsequent Antibody Response to HIV Infection
por: Ditse, Zanele, et al.
Publicado: (2020)

Harnessing the protective potential of HIV-1 neutralizing antibodies
por: Smith, S Abigail, et al.
Publicado: (2016)

Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study
por: Stieh, Daniel J, et al.
Publicado: (2022)

Co-evolution of HIV Envelope and Apex-Targeting Neutralizing Antibody Lineage Provides Benchmarks for Vaccine Design
por: Rantalainen, Kimmo, et al.
Publicado: (2018)

Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2
por: Breiman, Adrien, et al.
Publicado: (2020)

Sendai Virus-Vectored Vaccines That Express Envelope Glycoproteins of Respiratory Viruses
por: Russell, Charles J., et al.
Publicado: (2021)

HIV-1 vaccine design through minimizing envelope metastability
por: He, Linling, et al.
Publicado: (2018)

Stabilized diverse HIV-1 envelope trimers for vaccine design
por: Wang, Qian, et al.
Publicado: (2020)

Harnessing T Follicular Helper Cell Responses for HIV Vaccine Development
por: Niessl, Julia, et al.
Publicado: (2018)

Multi-trial analysis of HIV-1 envelope gp41-reactive antibodies among global recipients of candidate HIV-1 vaccines
por: Mayer-Blackwell, Koshlan, et al.
Publicado: (2022)

Instructional design /
por: Smith, Patricia L. (Patricia Lucille)
Publicado: (2005)

Harnessing Natural Killer Cell Innate and Adaptive Traits in HIV Infection
por: Alrubayyi, Aljawharah, et al.
Publicado: (2020)

Spatiotemporal hierarchy in antibody recognition against transmitted HIV-1 envelope glycoprotein during natural infection
por: Jin, Su, et al.
Publicado: (2016)

HIV-1 Envelope and MPER Antibody Structures in Lipid Assemblies
por: Rantalainen, Kimmo, et al.
Publicado: (2020)

The accidental instructional designer
por: Bean, Cammy
Publicado: (2014)

HIV-1 Envelope gp41 Broadly Neutralizing Antibodies: Hurdles for Vaccine Development
por: Verkoczy, Laurent, et al.
Publicado: (2014)

A Structural Update of Neutralizing Epitopes on the HIV Envelope, a Moving Target
por: Parker Miller, Emma, et al.
Publicado: (2021)

Cross-Reactive Immune Responses toward the Common Cold Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Mini-Review and a Murine Study
por: Sealy, Robert E., et al.
Publicado: (2021)

Selection of HIV Envelope Strains for Standardized Assessments of Vaccine-Elicited Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies
por: Mielke, Dieter, et al.
Publicado: (2022)

An injectable CRISPR therapy instructs B cells to produce anti-HIV antibodies
por: Collins, Logan Thrasher
Publicado: (2022)

Quantifying Anti-HIV Envelope-Specific Antibodies in Plasma from HIV Infected Individuals
por: Kant, Sanket, et al.
Publicado: (2019)

Entering a new era of harnessing natural killer cell responses in HIV infection
por: Peppa, Dimitra
Publicado: (2019)

Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
por: Torrents de la Peña, Alba, et al.
Publicado: (2018)

Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope
por: Schoofs, Till, et al.
Publicado: (2019)

Strategies for induction of HIV‐1 envelope‐reactive broadly neutralizing antibodies
por: Williams, Wilton B., et al.
Publicado: (2021)

Instructional design made easy
Publicado: (1999)

Instructional-design theories and models /
Publicado: (1983)

Mastering the Instructional Design Process
por: Rothwell, William
Publicado: (2015)

Instructional design for action learning
por: McArdle, Geri E H
Publicado: (2011)

Learning Science for Instructional Designers
por: Quinn, Clark
Publicado: (2021)

Harnessing self-assembled peptide nanoparticles in epitope vaccine design
por: Negahdaripour, Manica, et al.
Publicado: (2017)

Harnessing synthetic biology for advancing RNA therapeutics and vaccine design
por: Pfeifer, Blaine A., et al.
Publicado: (2023)

Harnessing Naturally Occurring Tumor Immunity: A Clinical Vaccine Trial in Prostate Cancer
por: Frank, Mayu O., et al.
Publicado: (2010)

Structure‐guided envelope trimer design in HIV‐1 vaccine development: a narrative review
por: Derking, Ronald, et al.
Publicado: (2021)

Tools to therapeutically harness the human antibody response
por: Wilson, Patrick C., et al.
Publicado: (2012)

Harnessing the power of antibodies to fight bone metastasis
por: Tian, Zeru, et al.
Publicado: (2021)

Harnessing Natural Diversity to Probe Metabolic Pathways
por: Homann, Oliver R, et al.
Publicado: (2005)

Harnessing γδ T Cells as Natural Immune Modulators
por: Hedges, Jodi F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4pmvuhddfuh41hqa5p3j803dfa